These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 1646001)
1. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. Yamashita Y; Kawada S; Fujii N; Nakano H Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001 [TBL] [Abstract][Full Text] [Related]
2. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Yamashita Y; Kawada S; Nakano H Biochem Pharmacol; 1990 Feb; 39(4):737-44. PubMed ID: 2154993 [TBL] [Abstract][Full Text] [Related]
3. Correlation between the formation of cleavable complex with topoisomerase I and growth-inhibitory activity for saintopin-type antibiotics. Fujii N; Yamashita Y; Mizukami T; Nakano H Mol Pharmacol; 1997 Feb; 51(2):269-76. PubMed ID: 9203632 [TBL] [Abstract][Full Text] [Related]
4. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins. Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310 [TBL] [Abstract][Full Text] [Related]
5. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs. Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264 [TBL] [Abstract][Full Text] [Related]
6. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. Tewey KM; Chen GL; Nelson EM; Liu LF J Biol Chem; 1984 Jul; 259(14):9182-7. PubMed ID: 6086625 [TBL] [Abstract][Full Text] [Related]
7. Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Yamashita Y; Fujii N; Murakata C; Ashizawa T; Okabe M; Nakano H Biochemistry; 1992 Dec; 31(48):12069-75. PubMed ID: 1333791 [TBL] [Abstract][Full Text] [Related]
8. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440 [TBL] [Abstract][Full Text] [Related]
9. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli. Huff AC; Leatherwood JK; Kreuzer KN Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1307-11. PubMed ID: 2537494 [TBL] [Abstract][Full Text] [Related]
10. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. Jensen PB; Sørensen BS; Demant EJ; Sehested M; Jensen PS; Vindeløv L; Hansen HH Cancer Res; 1990 Jun; 50(11):3311-6. PubMed ID: 2159380 [TBL] [Abstract][Full Text] [Related]
11. Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin. Fujii N; Yamashita Y; Arima Y; Nagashima M; Nakano H Antimicrob Agents Chemother; 1992 Dec; 36(12):2589-94. PubMed ID: 1336338 [TBL] [Abstract][Full Text] [Related]
12. Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity. Estey E; Adlakha RC; Hittelman WN; Zwelling LA Biochemistry; 1987 Jul; 26(14):4338-44. PubMed ID: 2822085 [TBL] [Abstract][Full Text] [Related]
13. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells. Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713 [TBL] [Abstract][Full Text] [Related]
14. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I. Prost S; Riou G Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110 [TBL] [Abstract][Full Text] [Related]
15. [Antitumor agents targeting mammalian topoisomerases]. Nakano H Gan To Kagaku Ryoho; 1991 Aug; 18(10):1550-5. PubMed ID: 1651681 [TBL] [Abstract][Full Text] [Related]
16. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Lin JH; Castora FJ Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases. Huff AC; Kreuzer KN J Biol Chem; 1990 Nov; 265(33):20496-505. PubMed ID: 2173709 [TBL] [Abstract][Full Text] [Related]
18. Induction of mammalian DNA topoisomerase II dependent DNA cleavage by antitumor antibiotic streptonigrin. Yamashita Y; Kawada S; Fujii N; Nakano H Cancer Res; 1990 Sep; 50(18):5841-4. PubMed ID: 2168283 [TBL] [Abstract][Full Text] [Related]
19. Induction of mammalian DNA topoisomerase I-mediated DNA cleavage and DNA winding by bulgarein. Fujii N; Yamashita Y; Saitoh Y; Nakano H J Biol Chem; 1993 Jun; 268(18):13160-5. PubMed ID: 8390457 [TBL] [Abstract][Full Text] [Related]
20. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA. Huff AC; Ward RE; Kreuzer KN Mol Gen Genet; 1990 Mar; 221(1):27-32. PubMed ID: 2157956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]